DGAP-News: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development

Issuer: CureVac / Key word(s): Alliance
CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development

25.05.2022 / 13:00
The issuer is solely responsible for the content of this announcement.
Quelle: Börse Online RSS Feed